Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Iovance Biotherapeutics Q2 Revenue USD 99.313 Million

BRIEF-Iovance Biotherapeutics Q2 Revenue USD 99.313 Million

ReutersReuters2026/08/06 11:02

Aug 06 (Reuters) - Iovance Biotherapeutics Q2 net income USD -47.315 million vs. IBES estimate USD -57.6 million.

  • Q2 operating income USD -51.905 million vs. IBES estimate USD -59.7 million
  • Q2 pretax profit USD -48.688 million vs. IBES estimate USD -59.8 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!